Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Journal of Hepatology|October 3, 2001
Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trialL Alric, M Duffaut, J Selves, et al.Radiology|February 1, 1993
Transjugular intrahepatic portosystemic shunt: evaluation with Doppler sonographyJ M Longo, J I Bilbao, H P Rousseau, et al.Gastroenterology|November 14, 1997
Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infectionL Alric, M Fort, J Izopet, et al.Journal of Virology|January 7, 2000
Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapyK Sandres, M Dubois, C Pasquier, et al.Gastroenterology|January 1, 1995
Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosisJ L Payen, P Calès, J J Voigt, et al.Gastroenterologie Clinique Et Biologique|January 1, 1992
[Evaluation of the effects of molsidomine and propranolol-molsidomine combination on portal hemodynamics by pulsed Doppler ultrasound]J L Monnin, J P Vinel, A Le Quellec, et al.Alimentary Pharmacology & Therapeutics|April 10, 2008
Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver diseaseC Bureau, S Metivier, J M Peron, et al.Gastroenterologie Clinique Et Biologique|January 1, 1994
[Enterovenous fistula. An unusual complication of Crohn disease]J L Payen, L Alric, F De Haldat, et al.Cardiovascular and Interventional Radiology|January 1, 1994
Transjugular intrahepatic portosystemic shunts using the Wallstent prosthesis: a follow-up studyH Rousseau, J P Vinel, J I Bilbao, et al.Hepatology (Baltimore, Md.)|May 1, 1997
Histopathologic analysis of transjugular intrahepatic portosystemic shuntsH Ducoin, J El-Khoury, H Rousseau, et al.Pageof 7